Amplify Answers Trademark Details
Word Mark | Amplify Answers |
---|---|
Status | Alive 641 — Non-Final Action - Mailed |
Current Owner
Adaptive Biotechnologies Corporation of Seattle, WA
View all trademarks for Adaptive Biotechnologies CorporationSerial Number | 86459438 |
---|---|
Status Date | Monday, March 21, 2016 |
Filing Date | Monday, March 21, 2016 |
Attorney | Hoang-chi Truong |
Correspondent
HOANG-CHI TRUONG
PATENT LAW WORKS LLP
201 S MAIN ST STE 250
SALT LAKE CITY, UT 84111-2359
PATENT LAW WORKS LLP
201 S MAIN ST STE 250
SALT LAKE CITY, UT 84111-2359
Case File Statements
Goods & Services | Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; providing clinical diagnostic assays and diagnostic or prognostic testing for detection of minimal residual disease in lymphoid malignancies; providing analysis, evaluation, and clinical reports of a patient's immune repertoire, including T cell or B cell clonal diversity and clone frequency; providing assays for tracking clones in an immune repertoire over time; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; providing diagnostic assays and diagnostic or prognostic testing for residual disease, and the analysis, evaluation, and reports of those test results to help healthcare professionals determine a patient's clinical diagnosis, prognosis or treatment, to assess the effectiveness of patient treatments, and to revise future treatments accordingly |
---|
Classifications
International Class Codes |
042
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 6 — Active |
Status Date | Wednesday, November 26, 2014 |
Primary Code | 042 |
Trademark Timeline
-
Nov 19 2014Trademark application filed with USPTO
-
Nov 22 2014New Application Entered In Tram
-
Nov 26 2014New Application Office Supplied Data Entered In Tram
-
Mar 09 2015Assigned To Examiner
-
Mar 10 2015Notification of Non-Final Action E-Mailed
-
Mar 10 2015Non-Final Action E-Mailed
-
Mar 10 2015Non-Final Action Written
-
Sep 11 2015Notice of Revival - E-Mailed
-
Sep 11 2015Teas/email Correspondence Entered
-
Sep 11 2015Correspondence Received In Law Office
-
Sep 11 2015Teas Response To Office Action Received
-
Sep 11 2015Petition To Revive-Granted
-
Sep 11 2015Teas Petition To Revive Received
-
Sep 15 2015Notification of Letter of Suspension E-Mailed
-
Sep 15 2015Letter of Suspension E-Mailed
-
Sep 15 2015Suspension Letter Written
-
Mar 18 2016Assigned To Lie
-
Mar 21 2016Notification of Non-Final Action E-Mailed
-
Mar 21 2016Non-Final Action E-Mailed
-
Mar 21 2016Non-Final Action Written